In previous studies, we demonstrated upregulation of FABP4 and CD36 in SARFIFA-positive gastric and colorectal cancers by investigating spatial and bulk RNA-data as well as immunohistochemical protein expression [7–9]. Here, FABP4 is linked to colorectal cancer.